Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Fall on the Road
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Absci Corp
(NQ:
ABSI
)
4.660
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
73
Open
4.660
Bid (Size)
4.560 (2)
Ask (Size)
5.090 (1)
Prev. Close
4.660
Today's Range
4.660 - 4.660
52wk Range
1.111 - 6.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Analyst Landscape: 4 Takes On Absci
March 06, 2024
Via
Benzinga
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
Performance
YTD
+26.29%
+26.29%
1 Month
-3.12%
-3.12%
3 Month
+54.82%
+54.82%
6 Month
+198.72%
+198.72%
1 Year
+194.01%
+194.01%
More News
Read More
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
March 01, 2024
From
Absci Corporation
Via
GlobeNewswire
Why Absci (ABSI) Shares Are Falling
February 28, 2024
Via
Benzinga
Absci Announces Pricing of Public Offering of Common Stock
February 27, 2024
From
Absci Corporation
Via
GlobeNewswire
Cracking The Code: Understanding Analyst Reviews For Absci
January 08, 2024
Via
Benzinga
Absci Announces Proposed Public Offering of Common Stock
February 27, 2024
From
Absci Corporation
Via
GlobeNewswire
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
February 21, 2024
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
February 20, 2024
From
Absci Corporation
Via
GlobeNewswire
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
February 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
iRobot, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 19, 2024
Via
Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
January 10, 2024
From
Absci Corporation
Via
GlobeNewswire
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in the 26th Annual Needham Growth Conference
January 03, 2024
From
Absci Corporation
Via
GlobeNewswire
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
Via
Talk Markets
Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Absci Corporation
Via
GlobeNewswire
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Via
Benzinga
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
December 20, 2023
From
Absci Corporation
Via
GlobeNewswire
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
December 11, 2023
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
December 04, 2023
From
Absci Corporation
Via
GlobeNewswire
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.